Breast cancer and economic concerns: How to do better?
Jean-Jacques ZAMBROWSKI
New User? Click here to register
Breast cancer treatment is no longer a one-size-fits-all approach. This shift away from standardized protocols recognizes that factors such as age, tumor biology, and overall health significantly influence treatment decisions. By considering these nuances, clinicians can develop tailored plans that optimize both effectiveness and quality of life for each patient.
Age plays a crucial role in shaping breast cancer management. Younger patients often present with more aggressive tumor biology, necessitating a more comprehensive approach that may include a combination of systemic therapy (chemotherapy, hormone therapy) and local treatment (surgery, radiation).
Conversely, elderly patients frequently exhibit less aggressive disease. In these cases, de-escalation strategies are often employed, minimizing invasive procedures and prioritizing treatments that maximize benefit while minimizing potential complications.
The future of breast cancer treatment lies in personalized medicine—continuously refining our understanding of individual patient profiles and tailoring treatment plans accordingly. This approach not only enhances effectiveness but also empowers patients to actively participate in their healthcare journey, leading to better outcomes and improved well-being.
This article has been reviewed and edited by Dr JP Minart
Text generated by AI based on an exclusive interview, revised and reviewed by
Jean-Jacques ZAMBROWSKI
Dana HADDAD
Copyright © 2025 - BCU